Clinical trial
Safety and Efficacy of Peri-procedural Use of Tirofiban in Elective Percutaneous Coronary Intervention for Long Coronary Lesions With Overlapping Drug-Eluting Stent
NCT01498003 is registered in ClinicalTrials.gov with Shanghai Jiao Tong University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Peri-procedural Use of Tirofiban in Elective Percutaneous Coronary Intervention for Long Coronary Lesions With Overlapping Drug-Eluting Stent
- Lead sponsor
- Shanghai Jiao Tong University School of Medicine
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2011
- Completion date
- June 30, 2014
- Enrollment
- 748 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.